Identification and characterization of the Plasmodium vivax thrombospondin-related apical merozoite protein

Background. Malaria caused by Plasmodium vivax is a major public health problem worldwide that affects 70-80 million people in the Middle East, Asia, Western Pacific, South America and the Caribbean. Despite its epidemiological importance, few antigens from this parasite species have been characterized to date compared to Plasmodium falciparum, due in part to the difficulties of maintaining an in vitro culture of P. vivax. This study describes the identification of the P. falciparum thrombospondin-related apical merozoite protein homologue in P. vivax (PvTRAMP) and examines its potential to be further evaluated as vaccine candidate. Methods. The gene encoding PvTRAMP was identified through an extensive search of the databases hosting the genome sequence of P. vivax. Genes adjacent to pvtramp were identified in silico to determine the degree of similarity between the protein sequences encoded by equivalent chromosomic fragments in P. falciparum and Plasmodium knowlesi. The pvtramp gene was amplified from cDNA of P. vivax schizont stages, cloned and expressed in Escherichia coli. Anti-PvTRAMP antisera was obtained by inoculating rabbits with PvTRAMP B cell epitopes produced as synthetic peptides in order to assess its recognition in parasite lysates by Western blot and in intact parasites by indirect immunofluorescence. The recognition of recombinant PvTRAMP by sera from P. vivax-infected individuals living in endemic areas was also assessed by ELISA. Results. The PfTRAMP homologue in P. vivax, here denoted as PvTRAMP, is a 340-amino-acid long antigen encoded by a single exon that could have a potential role in cytoadherence, as indicated by the presence of a thrombospondin structural homology repeat (TSR) domain. According to its transcription and expression profile, PvTRAMP is initially located at the parasite's apical end and later on the parasite surface. Recombinant PvTRAMP is recognized by sera from infected patients, therefore, indicating that it is targeted by the immune system during a natural infection with P. vivax. Conclusions. The results of this work support conducting further studies with PvTRAMP to evaluate its immunogenicity and protection-inducing ability in the Aotus animal model. © 2010 Mongui et al; licensee BioMed Central Ltd.

• Fecha de publicación: 2010
• Institución: Universidad del Rosario
• Repositorio: Repositorio EdocUR - U. Rosario
• Idioma: eng
• OAI Identifier: oai:repository.urosario.edu.co:10336/22551
• Acceso en línea: https://doi.org/10.1186/1475-2875-9-283; https://repository.urosario.edu.co/handle/10336/22551
• Palabra clave: Antiserum; Complementary dna; Epitope; Recombinant protein; Synthetic peptide; Thrombospondin; Thrombospondin related apical merozoite protein; Unclassified drug; Complementary dna; Malaria vaccine; Membrane antigen; Parasite antigen; Protozoal dna; Protozoal protein; Protozoon antibody; Thrombospondin; Amino acid sequence; Animal cell; Aotus; Article; Cell lysate; Chromosome; Enzyme linked immunosorbent assay; Escherichia coli; Exon; Gene; Gene amplification; Gene expression profiling; Gene identification; Gene sequence; Genetic transcription; Immune system; Immunofluorescence; Immunogenicity; Inoculation; Molecular cloning; Nonhuman; Nucleotide sequence; Plasmodium knowlesi; Plasmodium vivax; Protein analysis; Protein domain; Pvtramp gene; Rabbit; Schizont; Structural homology; Western blotting; Animal; Biology; Blood; Colombia; Fluorescence microscopy; Gene expression; Genetics; Human; Immunology; Isolation and purification; Merozoite; Sequence homology; Animals; Colombia; Computational biology; Enzyme-linked immunosorbent assay; Escherichia coli; Gene expression; Humans; Malaria vaccines; Merozoites; Plasmodium vivax; Protozoan proteins; Rabbits; Thrombospondins; fluorescence; western; surface; protozoan; protozoan; protozoan; molecular; complementary; amino acid; Antibodies; Antigens; Antigens; Blotting; Cloning; Dna; Dna; Microscopy; Sequence homology
• License: Abierto (Texto Completo)